BOSTON SCIENTIFIC CORP — Director's Dealing 2025

Feb 26, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2025-02-24

Reporting Person: Fitzgerald Joseph Michael (EVP & Group Pres, Cardiology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-24	Common Stock	G	1700.0000	$0.0000	Disposed	178682.0000	Direct
2025-02-25	Common Stock	G	340.0000	$0.0000	Disposed	178342.0000	Direct
2025-02-24	Common Stock	G	340.0000	$0.0000	Acquired	5234.0000	Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.